Reflexology: An Intervention for Acute Myeloid Leukemia(AML) Patients

Reflexology Treatment for Newly Diagnosed AML Patients, Can it Reduce GI Tract Side Effects, and Improve and Improve Patients Mood.

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02863302

Enrollment

Registered

2016-08-11

Start date

2017-01-01

Completion date

2018-06-30

Last updated

2017-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myeloid Leukemia

Keywords

Acute Myeloid Leukemia, Reflexology

Brief summary

The aim of this study is to test a complementary therapy intervention (reflexology) that will assist in improving quality of life (QOL) for patients undergoing chemotherapy for acute myeloid leukemia. within the context of conventional medical care. Quality of life will be assessed via intermediate indicators: 1) physical indicators (greater physical functioning, lower presence of symptoms) 2) emotional indicators (greater spirituality, lower anxiety, and lower depressive symptomology); by a specific questionnaire. 3) chemotherapy side effects associated with the digestive system.

Detailed description

The goal of this study is to test a complementary therapy intervention that will assist in improving quality of life (QOL) for patients undergoing chemotherapy for acute myeloid leukemia within the context of conventional medical care. This open study will test a one group design in which participants will continue to receive conventional care. All patients will receive reflexology (a specialized foot therapy) from a certified reflexologist twice weekly from the beginning of chemotherapy treatment. The specific aims are: 1) to evaluate the effect of reflexology treatment on chemotherapy side effects effecting the digestive system. 2) to evaluate the effect of reflexology treatment on Quality of life. The assessment of the treatment will be executed on the FACIT-D VERSION 3.The influences of the treatment will also be evaluated by the nursing staff, in order to describe the patient's mental health and the condition of his intestinal movement.The side effect before during and after the chemotherapy treatment will be compared using the questionnaire.

Interventions

OTHERReflexology treatment

All patients will receive reflexology (a specialized foot therapy) from a certified reflexologist twice weekly from the beginning of chemotherapy treatment.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* diagnosis of AML * chemotherapy treatment * signing a consent form.

Exclusion criteria

• Not willing to sign a consent form.

Design outcomes

Primary

Measure	Time frame
Change from baseline in the FACIT-D questionaire.	Change from baseline in the FACIT-D questionaire at 1,2,3, and 4 weeks from the beginning of chemotherapy treatment.

Secondary

Measure	Time frame	Description
To evaluate the effect of reflexology treatment on chemotherapy associated diarrhea	Diarrhea frequency will be recorded daily from the first day of chemotherapy and up to 30 days.	Diarrhea frequency will be recorded daily by the nursing staff and entered into the patients medical chart.

Countries

Israel

Contacts

Primary ContactNetanel A Horowitz, MD

n_horowitz@rambam.health.gov.il97247772541

Backup ContactLimor Dan, Msc

l_dan@rambam.health.gov.il97247772541

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026